Details for Patent: RE41065

✉ Email this page to a colleague

Summary for Patent: RE41065

Patent landscape, scope, and claims:

Title:	Alkynl and azido-substituted 4-anilinoquinazolines
Abstract:	The invention relates to compounds of the formula ##STR00001## and to pharmaceutically acceptable salts thereof, wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, n and m are as defined herein. The compounds of formula I are useful in the treatment of hyperproliferative diseases, such as cancer. The invention further relates to processes of making the compounds of formula I and to methods of using such compounds in the treatment of hyperproliferative diseases.
Inventor(s):	Schnur; Rodney Caughren (Noank, CT), Arnold; Lee Daniel (Mt. Sinai, NY)
Assignee:	Pfizer, Inc. (New York, NY) OSI Pharmaceuticals, Inc. (Melville, NY)
Application Number:	12/038,530
Patent Claim Types: see list of patent claims	Compound; Use; Composition; Process;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent RE41065

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent RE41065

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	0817775	⤷ Subscribe	300214	Netherlands	⤷ Subscribe
European Patent Office	0817775	⤷ Subscribe	91209	Luxembourg	⤷ Subscribe
European Patent Office	0817775	⤷ Subscribe	SPC/GB06/008	United Kingdom	⤷ Subscribe
European Patent Office	0817775	⤷ Subscribe	06C0010	France	⤷ Subscribe
European Patent Office	0817775	⤷ Subscribe	CA 2006 00006	Denmark	⤷ Subscribe
European Patent Office	0817775	⤷ Subscribe	C00817775/01	Switzerland	⤷ Subscribe
European Patent Office	0817775	⤷ Subscribe	SPC001/2006	Ireland	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.